Association of glucose homeostasis measures with heart rate variability among Hispanic/Latino adults without diabetes: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

Cardiovascular Diabetology

Volumn 15, Issue 1, 2016, Pages

  Meyer, Michelle L ^a   Gotman, Nathan M ^a   Soliman, Elsayed Z ^b   Whitsel, Eric A ^a   Arens, Raanan ^c   Cai, Jianwen ^a   Daviglus, Martha L ^d   Denes, Pablo ^e   González, Hector M ^f   Moreiras, Juan ^g   Talavera, Gregory A ^h   Heiss, Gerardo ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f MICHIGAN STATE UNIVERSITY   (United States)

^g UNIVERSITY OF MIAMI   (United States)

^h SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Autonomic function; Cohort study; Insulin resistance; Parasympathetic and sympathetic nervous system; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; BIOLOGICAL MARKER; GLYCATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; DIET RESTRICTION; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE HOMEOSTASIS; HEART FAILURE; HEART RATE VARIABILITY; HISPANIC; HOUSEHOLD; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROBABILITY; RR INTERVAL; SAMPLING; UNITED STATES; WAIST CIRCUMFERENCE; ADOLESCENT; AUTONOMIC NERVOUS SYSTEM; BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; ETHNOLOGY; FASTING; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HEART; HEART RATE; HOMEOSTASIS; INNERVATION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RISK FACTOR; SEX FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUTONOMIC NERVOUS SYSTEM; BIOMARKERS; BLOOD GLUCOSE; FASTING; FEMALE; GLYCATED HEMOGLOBIN; HEALTH STATUS; HEART; HEART RATE; HISPANIC OR LATINO; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY, ABDOMINAL; RISK FACTORS; SEX FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84962159671     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-016-0364-y     Document Type: Article

References (50)

1. Tentolouris N, Argyrakopoulou G, Katsilambros N. Perturbed autonomic nervous system function in metabolic syndrome. Neuro Mol Med. 2008;10(3):169-78.
2. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553-79.
3. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the atherosclerosis risk in communities study, 1987-1998. Circulation. 2003;107(17):2190-5.
4. Gerritsen J, Dekker JM, TenVoorde BJ, Bertelsmann FW, Kostense PJ, Stehouwer CD, et al. Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia. 2000;43(5):561-70.
5. Stein PK, Barzilay JI, Domitrovich PP, Chaves PM, Gottdiener JS, Heckbert SR, et al. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the cardiovascular health study. Diabet Med. 2007;24(8):855-63.
6. Min KB, Min JY, Paek D, Cho SI. The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions. Pacing Clin Electrophysiol. 2008;31(5):584-91.
7. Koskinen T, Kahonen M, Jula A, Mattsson N, Laitinen T, Keltikangas-Jarvinen L, et al. Metabolic syndrome and short-term heart rate variability in young adults. The cardiovascular risk in young Finns study. Diabet Med. 2009;26(4):354-61.
8. Malfitano C, Barboza CA, Mostarda C, da Palma RK, dos Santos CP, Rodrigues B, et al. Diabetic hyperglycemia attenuates sympathetic dysfunction and oxidative stress after myocardial infarction in rats. Cardiovascular diabetology. 2014;13:131.
9. Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD, et al. Diabetes, glucose, insulin, and heart rate variability: the atherosclerosis risk in communities (ARIC) study. Diabetes Care. 2005;28(3):668-74.
10. Ziegler D, Zentai C, Perz S, Rathmann W, Haastert B, Meisinger C, et al. Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes. 2006;114(4):153-9.
11. Perciaccante A, Fiorentini A, Paris A, Serra P, Tubani L. Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC cardiovasc Disord. 2006;6:19.
12. Singh JP, Larson MG, O'Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000;86(3):309-12.
13. Watkins LL, Surwit RS, Grossman P, Sherwood A. Is there a glycemic threshold for impaired autonomic control? Diabetes Care. 2000;23(6):826-30.
14. Daviglus ML, Talavera GA, Aviles-Santa ML, Allison M, Cai J, Criqui MH, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA. 2012;308(17):1775-84.
15. Heiss G, Snyder ML, Teng Y, Schneiderman N, Llabre MM, Cowie C, et al. Prevalence of metabolic syndrome among Hispanics/Latinos of diverse background: the Hispanic community health study/study of Latinos. Diabetes Care. 2014;37(8):2391-9.
16. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290(14):1884-90.
17. Sorlie PD, Aviles-Santa LM, Wassertheil-Smoller S, Kaplan RC, Daviglus ML, Giachello AL, et al. Design and implementation of the Hispanic Community Health study/Study of Latinos. Ann Epidemiol. 2010;20(8):629-41.
18. Lavange LM, Kalsbeek WD, Sorlie PD, Aviles-Santa LM, Kaplan RC, Barnhart J, et al. Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol. 2010;20(8):642-9.
19. Heart rate variability. standards of measurement, physiological interpretation and clinical use; Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93(5):1043-65.
20. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(1):62-9.
21. Rautaharju PM, Wolf HK, Eifler WJ, Blackburn H. A simple procedure for positioning precordial ECG and VCG electrodes using an electrode locator. J Electrocardiol. 1976;9(1):35-40.
22. Rautaharju PM, Park L, Rautaharju FS, Crow R. A standardized procedure for locating and documenting ECG chest electrode positions: consideration of the effect of breast tissue on ECG amplitudes in women. J Electrocardiol. 1998;31(1):17-29.
23. Rothman KJ. Significance Questing. Ann Intern Med. 1986;105(3):445-7.
24. Albers JW, Brown MB, Sima AA, Greene DA. Nerve conduction measures in mild diabetic neuropathy in the early diabetes intervention trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial. Neurology. 1996;46(1):85-91.
25. Aaberg ML, Burch DM, Hud ZR, Zacharias MP. Gender differences in the onset of diabetic neuropathy. J Diabetes Complications. 2008;22(2):83-7.
26. Franconi F, Campesi I, Occhioni S, Tonolo G. Sex-gender differences in diabetes vascular complications and treatment. Endocr Metab Immune Disord Drug Targets. 2012;12(2):179-96.
27. Nolan RP, Barry-Bianchi SM, Mechetiuc AE, Chen MH. Sex-based differences in the association between duration of type 2 diabetes and heart rate variability. Diabetes Vasc Dis Res. 2009;6(4):276-82.
28. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002;106(20):2533-6.
29. Grassi G, Dell'Oro R, Facchini A. Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens. 2004;22(12):2363-9.
30. Straznicky NE, Eikelis N, Lambert EA, Esler MD. Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep. 2008;10(6):440-7.
31. Lindmark S, Lonn L, Wiklund U, Tufvesson M, Olsson T, Eriksson JW. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance. Obes Res. 2005;13(4):717-28.
32. Paolisso G, Manzella D, Montano N, Gambardella A, Varricchio M. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab. 2000;85(5):1810-4.
33. Pieterse C, Schutte R, Schutte AE. Autonomic activity and leptin in Africans and whites: the SABPA study. J Hypertens. 2014;32(4):826-33.
34. Charles LE, Burchfiel CM, Sarkisian K, Li S, Miller DB, Gu JK, et al. Leptin, adiponectin, and heart rate variability among police officers. Am J Hum Biol. 2015;27(2):184-91.
35. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Investig. 1991;87(6):2246-52.
36. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Investig. 1994;93(6):2365-71.
37. Van De Borne P, Hausberg M, Hoffman RP, Mark AL, Anderson EA. Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects. Am J Physiol. 1999;276(1 Pt 2):R178-83.
38. Plum L, Schubert M, Bruning JC. The role of insulin receptor signaling in the brain. Trends Endocrinol Metabol. 2005;16(2):59-65.
39. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev. 1992;13(3):387-414.
40. Schwartz MW, Figlewicz DP, Woods SC, Porte D Jr, Baskin DG. Insulin, neuropeptide Y, and food intake. Ann N Y Acad Sci. 1993;692:60-71.
41. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404(6778):661-71.
42. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25(5):932-43.
43. Meerwaldt R, Links TP, Graaff R, Hoogenberg K, Lefrandt JD, Baynes JW, et al. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia. 2005;48(8):1637-44.
44. Schroeder EB, Whitsel EA, Evans GW, Prineas RJ, Chambless LE, Heiss G. Repeatability of heart rate variability measures. J Electrocardiol. 2004;37(3):163-72.
45. de Bruyne MC, Kors JA, Hoes AW, Klootwijk P, Dekker JM, Hofman A, et al. Both decreased and increased heart rate variability on the standard 10-s electrocardiogram predict cardiac mortality in the elderly: the Rotterdam Study. Am J Epidemiol. 1999;150(12):1282-8.
46. Lombardi F. Clinical implications of present physiological understanding of HRV components. Card Electrophysiol Rev. 2002;6(3):245-9.
47. Brotman DJ, Bash LD, Qayyum R, Crews D, Whitsel EA, Astor BC, et al. Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol. 2010;21(9):1560-70.
48. Rautaharju PM, Kooperberg C, Larson JC, LaCroix A. Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: the Women's Health Initiative. Circulation. 2006;113(4):473-80.
49. Liao D, Carnethon M, Evans GW, Cascio WE, Heiss G. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes. 2002;51(12):3524-31.
50. Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol. 1997;145(10):899-908.